Prediction: Artificial Intelligence (AI) Will Reshape This Industry by 2030. This Stock Could Lead.The Motley Fool • 01/29/26
Eli Lilly partners with Seamless Therapeutics on gene editing treatments for hearing lossProactive Investors • 01/28/26
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 01/28/26
Exclusive: Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data showsReuters • 01/28/26
Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker?The Motley Fool • 01/26/26
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q4 EarningsZacks Investment Research • 01/23/26
What obesity drugmakers see next in the market: More pills, easier access and drug combinationsCNBC • 01/23/26
FDA Grants Breakthrough Therapy Tag to LLY's Ovarian Cancer CandidateZacks Investment Research • 01/21/26
Lilly confirms date and conference call for fourth-quarter 2025 financial results announcementPRNewsWire • 01/21/26
Polen Focus Growth Portfolio Q4 2025 Performance, Attribution & Portfolio ActivitySeeking Alpha • 01/21/26
Lilly's sofetabart mipitecan receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancerPRNewsWire • 01/20/26